Immunovant Inc
(NASDAQ:IMVT)
$39.13
0.89[2.33%]
Last update: 4:33PM (Delayed 15-Minutes)
Get Real Time Here
$39.13
0[0.00%]
After-Hours
Open38.810Close39.130
Vol / Avg.3.046M / 2.187MMkt Cap5.661B
Day Range38.470 - 40.90052 Wk Range12.420 - 44.190

Immunovant Stock (NASDAQ:IMVT), Quotes and News Summary

Immunovant Stock (NASDAQ: IMVT) stock price, news, charts, stock research, profile.

Open38.810Close39.130
Vol / Avg.3.046M / 2.187MMkt Cap5.661B
Day Range38.470 - 40.90052 Wk Range12.420 - 44.190
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2024Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2024Est.ActualSurprise
EPS-0.480-0.450 0.0300
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-11-15Truist SecuritiesRobyn KarnauskasMaintainsBuyBuyRaises30.0048.00
2023-10-24Piper SandlerYasmeen RahimiMaintainsOverweightOverweightRaises28.0057.00
2023-10-24HC Wainwright & Co.Douglas TsaoMaintainsBuyBuyRaises29.0047.00
2023-10-16Cantor FitzgeraldLouise ChenMaintainsOverweightOverweightRaises30.0045.00

Related Companies

TickerCompanyChg %Mkt Cap
IMVTImmunovant2.33%5.7B
LEGNLegend Biotech2.83%11.2B
EXASExact Sciences-1.63%11.6B
SRPTSarepta Therapeutics1.37%7.6B
NBIXNeurocrine Biosciences2.69%11.5B
Q

How do I buy Immunovant (IMVT) stock?

A

You can purchase shares of Immunovant (NASDAQ: IMVT) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Immunovant (IMVT) stock?

A

The latest price target for Immunovant (NASDAQ: IMVT) was reported by Truist Securities on Wednesday, November 15, 2023. The analyst firm set a price target for 48.00 expecting IMVT to rise to within 12 months (a possible 22.67% upside). 35 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Immunovant (IMVT)?

A

The stock price for Immunovant (NASDAQ: IMVT) is $39.13 last updated November 30, 2023 at 9:33 PM UTC.

Q

Does Immunovant (IMVT) pay a dividend?

A

There is no dividend information for Immunovant.

Q

When is Immunovant (NASDAQ:IMVT) reporting earnings?

A

Immunovant’s Q3 earnings are confirmed for Friday, February 2, 2024.

Q

Is Immunovant (IMVT) going to split?

A

There is no upcoming split for Immunovant.

Q

What sector and industry does Immunovant (IMVT) operate in?

A

Immunovant is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.